is a common entity causing healthcare-associated diarrhea, the primary pathogen for antibiotic-associated colitis, and an important cause of infectious disease–associated mortality in the United States.
These conditions constitute the second leading cause of infection-related mortality in the ICU.
Aspergillosis, which is most commonly observed in immunocompromised persons, is a significant cause of morbidity and mortality in this population, with mortality rates as high as 90%.
Highly contagious and environmentally stable, strains of this viral pathogen are now the leading cause of diarrheal diseases across all age groups.
Many patients continue to experience significant discomfort for months or years after ICU discharge.
Mucositis—the breakdown of epithelial cells in the gastrointestinal tract—is a common and painful side effect of treatment for many cancer patients.
Oral phosphate binders are widely used in clinical practice for patients with end-stage renal disease.
The number of patients in need of hospice and palliative care continues to grow, as do the general population’s knowledge and awareness of the diagnosed conditions that render patients eligible for hospice care services.
Gliomas are central nervous system tumors that arise from glial cells in the brain or spine.
Complications seen with percutaneous coronary intervention led to the development of bare metal stents and, later, drug-eluting stents.
Recently updated guidelines have expanded the time window eligibility for treatment.
There are nine clearly defined types of muscular dystrophy, each differing in age of onset, clinical symptomology, muscle groups impacted, and associated complications.
Drug-induced bleeding presents in many ways, including excessive bruising, nosebleeds, heavy menses, gastrointestinal bleeding, and rectal bleeding.
Overutilization of PPIs has led to higher hospital-related costs and more adverse effects.
Practitioners must consider the increased potential for drug-induced liver injury in patients with preexisting liver disease.
There are many reasons for the occurrence of cognitive impairment in patients during hospitalization, and this impairment can have a long-term impact post discharge.
Patients should be monitored for increased intracranial pressure and seizure occurrence.
Differential diagnosis of a panic attack is critical to providing appropriate drug therapy.
QT-interval prolongation is estimated to occur in up to 10% of patients taking antiarrhythmic drugs with QT-prolonging potential.
New therapies prevent and reduce the duration and severity of swelling episodes.
For more articles, please check our archives.